Lung Inflammation Is Associated with Preeclampsia Development in the Rat

Area of Science:

• Obstetrics and Gynecology
• Pulmonology
• Molecular Biology

Background:

• Preeclampsia (PE) is a serious pregnancy complication with implications for maternal and fetal health.
• A link between lung disease and PE has been observed.
• Gas6 protein, found in the lung and placenta, interacts with the AXL receptor tyrosine kinase.

Purpose of the Study:

• To investigate the role of Gas6/AXL signaling in the maternal lung during the development of preeclampsia.
• To determine if Gas6 can induce preeclampsia-like symptoms and associated lung inflammation.

Main Methods:

• Pregnant rats were treated with Gas6 or Gas6 plus an AXL inhibitor (R428).
• Immunofluorescence, Western blot, and ELISA were used to analyze AXL expression, signaling pathways (ERK, AKT), and inflammatory cytokines.
• Bronchoalveolar lavage fluid (BALF) was analyzed for inflammatory markers and protein content.

Main Results:

• Gas6 treatment resulted in increased proteinuria and blood pressure, mimicking PE.
• AXL expression was elevated in the lungs of Gas6-treated rats.
• BALF analysis showed increased total protein and inflammatory cytokines in Gas6-treated animals, indicating lung inflammation.
• Gas6 signaling influenced ERK and AKT pathways in the lung.

Conclusions:

• Gas6 signaling is sufficient to induce preeclampsia-like conditions in a rat model.
• PE development mediated by Gas6 is associated with significant inflammation in the maternal lung.
• The Gas6/AXL pathway is a potential target for understanding and managing PE-related lung complications.